
Abbott Labs (ABT) Stock Forecast & Price Target
Abbott Labs (ABT) Analyst Ratings
Bulls say
Abbott Laboratories is positioned to succeed due to its diversified healthcare portfolio, strong commercial strategy, and key system advantages in its various product categories. With a strong pipeline of new products and expansion into emerging markets, Abbott is poised to continue its growth in sales and EPS. The company also has a strong track record of capital deployment and cash generation, making it a compelling investment opportunity.
Bears say
Abbott Laboratories is experiencing strong growth in the EP market and the success of its Exact Sciences acquisition is expected to lead to further growth in the cancer diagnostics market. However, potential risks such as geopolitical tensions and unfavorable changes in healthcare regulations could impact profitability. The company's Nutritional Products segment has shown a decline in sales but management is implementing strategies to improve volume growth and launch new products. The company also faces risks related to patent and trademark protection and litigation. Despite some positive developments, the potential for negative impact on profitability from external factors warrants a negative outlook on Abbott's stock.
This aggregate rating is based on analysts' research of Abbott Labs and is not a guaranteed prediction by Public.com or investment advice.
Abbott Labs (ABT) Analyst Forecast & Price Prediction
Start investing in Abbott Labs (ABT)
Order type
Buy in
Order amount
Est. shares
0 shares